Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.24.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows from Operating Activities:    
Net loss $ (1,542,332) $ (4,457,396)
Adjustment to reconcile net loss to net cash used in operating activities:    
Income from cash and investments held in Trust Account (550,901) (1,829,595)
Change in fair value of derivative warrant liabilities (394,000) 295,500
Change in fair value of working capital loans - related party (800)
Stock compensation expense 3,483,444
Gain from extinguishment of deferred underwriting commissions (362,250)
Changes in operating assets and liabilities:    
Prepaid expenses (21,250) (1,645)
Due from related party (26,165)
Accounts payable 307,124 1,723,402
Accrued expenses 1,678,934 550,980
Net cash used in operating activities (548,590) (598,360)
Cash Flows from Investing Activities:    
Cash deposited in Trust Account (235,157)
Cash withdrawn from Trust Account in connection with redemption 19,930,984 273,410,361
Net cash provided by investing activities 19,695,827 273,410,361
Cash Flows from Financing Activities:    
Proceeds from issuance of working capital loans to related party 677,500 594,000
Proceeds from advances from related party 72,700
Redemption of Ordinary shares (19,930,984) (273,410,361)
Net cash used in financing activities (19,180,784) (272,816,361)
Net change in cash (33,547) (4,360)
Cash - beginning of the period 39,582 21,548
Cash - end of the period 6,035 17,188
Supplemental disclosure of noncash financing activities:    
Accounts payable and accrued expenses paid by the Sponsor 16,000 20,930
Forgiveness of deferred underwriting fee payable allocated to Class A ordinary shares $ 9,700,250